Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A

Fig. 5

Merged flow cytometric histograms and fluorescence quantitative bar graphs of Mitotracker Deep Red FM in HEK293 cells treated with the preparations after 4 h (a) and 24 h (b). Merged flow cytometric histograms and fluorescence quantitative bar graphs of Rhodamine 123 in HEK293 cells treated with the preparations after 4 h (c) and 24 h (d). ***p < 0.001 vs N.S., *p < 0.05 vs N.S., **p < 0.01 vs N.S., â–³p < 0.05 vs DOX/Sal A solution, △△△p < 0.001 vs DOX/Sal A solution, ☆☆p < 0.01 vs NLC-DOX/Sal A, ☆☆☆p < 0.001 vs NLC-DOX/Sal A. Results are expressed as mean ± SD, n = 3

Back to article page